{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rod+Dystrophy&page=2", "query": { "condition": "Rod Dystrophy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rod+Dystrophy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T23:55:26.273Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05748873", "title": "Promising ROd-cone DYstrophy Gene therapY", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Retinitis Pigmentosa" ], "interventions": [ { "name": "SPVN06", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SparingVision", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2023-04-12", "completion_date": "2031-02", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 5, "location_summary": "Miami, Florida • Boston, Massachusetts • Portland, Oregon + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Portland", "state": "Oregon" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05748873" }, { "nct_id": "NCT06445322", "title": "Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stargardt Disease", "Stargardt Disease 1", "Cone Rod Dystrophy", "Juvenile Macular Degeneration" ], "interventions": [ { "name": "Prescreening Assessments", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Ascidian Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 50, "start_date": "2024-06-20", "completion_date": "2030-08-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 8, "location_summary": "San Francisco, California • Gainesville, Florida • Baltimore, Maryland + 5 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06445322" }, { "nct_id": "NCT02435940", "title": "Inherited Retinal Degenerative Disease Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Eye Diseases Hereditary", "Retinal Disease", "Achromatopsia", "Bardet-Biedl Syndrome", "Bassen-Kornzweig Syndrome", "Batten Disease", "Best Disease", "Choroidal Dystrophy", "Choroideremia", "Cone Dystrophy", "Cone-Rod Dystrophy", "Congenital Stationary Night Blindness", "Enhanced S-Cone Syndrome", "Fundus Albipunctatus", "Goldmann-Favre Syndrome", "Gyrate Atrophy", "Juvenile Macular Degeneration", "Kearns-Sayre Syndrome", "Leber Congenital Amaurosis", "Refsum Syndrome", "Retinitis Pigmentosa", "Retinitis Punctata Albescens", "Retinoschisis", "Rod-Cone Dystrophy", "Rod Dystrophy", "Rod Monochromacy", "Stargardt Disease", "Usher Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Foundation Fighting Blindness", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 20000, "start_date": "2014-06", "completion_date": "2037-06", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 1, "location_summary": "Columbia, Maryland", "locations": [ { "city": "Columbia", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02435940" }, { "nct_id": "NCT01920867", "title": "Stem Cell Ophthalmology Treatment Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Retinal Disease", "Macular Degeneration", "Hereditary Retinal Dystrophy", "Optic Nerve Disease", "Glaucoma" ], "interventions": [ { "name": "RB (Retrobulbar)", "type": "PROCEDURE" }, { "name": "ST (Subtenon)", "type": "PROCEDURE" }, { "name": "IV (Intravenous)", "type": "PROCEDURE" }, { "name": "IVIT (Intravitreal)", "type": "PROCEDURE" }, { "name": "IO (Intraocular)", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "MD Stem Cells", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2012-08", "completion_date": "2020-07", "has_results": false, "last_update_posted_date": "2019-10-23", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 1, "location_summary": "Westport, Connecticut", "locations": [ { "city": "Westport", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01920867" }, { "nct_id": "NCT03322930", "title": "Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Retinitis Pigmentosa", "AMD" ], "interventions": [ { "name": "Rod sensitivity", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Retina Foundation of the Southwest", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "10 Years to 85 Years" }, "enrollment_count": 40, "start_date": "2017-10-01", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2019-12-23", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03322930" }, { "nct_id": "NCT06467344", "title": "Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stargardt Disease", "Cone Rod Dystrophy", "Juvenile Macular Degeneration", "Stargardt Disease 1" ], "interventions": [ { "name": "ACDN-01", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ascidian Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 15, "start_date": "2024-06-11", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 10, "location_summary": "San Francisco, California • Gainesville, Florida • Miami, Florida + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06467344" }, { "nct_id": "NCT05294978", "title": "EyeConic: Qualification for Cone-Optogenetics", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Retinal Dystrophies" ], "interventions": [ { "name": "Optical coherence tomography (OCT)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Institute of Molecular and Clinical Ophthalmology Basel", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2021-07-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-07-31", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 3, "location_summary": "San Francisco, California • Miami, Florida • Pittsburgh, Pennsylvania", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05294978" }, { "nct_id": "NCT06395285", "title": "Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "ROSAH" ], "interventions": [ { "name": "DF-003", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2025-05-27", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 3, "location_summary": "Bethesda, Maryland • Durham, North Carolina • Salt Lake City, Utah", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06395285" }, { "nct_id": "NCT02338973", "title": "Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Inherited Ophthalmic Diseases", "Inherited Retinal Degeneration" ], "interventions": [ { "name": "Interferon gamma-1b", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 4, "start_date": "2015-01-14", "completion_date": "2018-07-26", "has_results": true, "last_update_posted_date": "2019-08-13", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02338973" }, { "nct_id": "NCT05355415", "title": "Adaptive Optics Imaging of Outer Retinal Diseases", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Retinal Degeneration", "Age-Related Macular Degeneration", "Retinitis Pigmentosa", "Hydroxychloroquine Retinopathy", "Usher Syndromes", "Late-Onset Retinal Degeneration", "Cone Dystrophy", "Cone Rod Dystrophy", "Rod Cone Dystrophy", "Rod Dystrophy" ], "interventions": [ { "name": "Adaptive optics imaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Food and Drug Administration (FDA)", "sponsor_class": "FED", "healthy_volunteers": null, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 100, "start_date": "2021-08-27", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-06-10T23:55:26.273Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Silver Spring, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Silver Spring", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05355415" } ] }